Hypertension and Antihypertensive Therapy in Hispanics and Mexican Americans Living in the United States

References

• . Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004. Hypertension. 2007; 49(1):69–75
   PubMed Web of Science ®Google Scholar
• . Chobanian AV, Bakris GL, Black HR, ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42(6):1206–1252
   PubMed Web of Science ®Google Scholar
• . World Health Organization. Cardiovascular diseases (CVDs). Fact sheet no 317. Geneva, Switzerland: WHO; 2009
   Google Scholar
• . Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA. 2010; 303(20): 2043–2050
   PubMed Web of Science ®Google Scholar
• . Ostchega Y, Yoon SS, Hughes J, Louis T. Hypertension awareness, treatment, and control—continued disparities in adults: United States, 2005–2006. NCHS Data Brief. 2008; 3:1–8
   PubMedGoogle Scholar
• . Brewster LM, van Montfrans GA, Kleijnen J. Systematic review: Antihypertensive drug therapy in black patients. Ann Intern Med. 2004; 141(8):614–627
   PubMedGoogle Scholar
• . Humes KR, Jones NA, Ramirez RR. Overview of race and Hispanic origin: 2010. Washington, DC: US Census Bureau; 2011
   Google Scholar
• . Caralis PV. Hypertension in the Hispanic-American population. Am J Med. 1990; 88(3B):9S–16S
   PubMedGoogle Scholar
• . Pickering TG. Hypertension in Hispanics. J Clin Hypertens (Greenwich). 2004; 6(5):279–282
   PubMedGoogle Scholar
• . Cooper-DeHoff RM, Aranda JM Jr, Gaxiola E, . Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients—findings from the International Verapamil SR/Trandolapril Study (INVEST). Am Heart J. 2006; 151(5):1072–1079
   PubMedGoogle Scholar
• . Cooper-DeHoff RM, Zhou Q, Gaxiola E, . Influence of Hispanic ethnicity on blood pressure control and cardiovascular outcomes in women with CAD and hypertension: Findings from INVEST. J Womens Health (Larchmt). 2007; 16(5):632–640
   PubMed Web of Science ®Google Scholar
• . Margolis KL, Piller LB, Ford CE, . Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension. 2007; 50(5):854–861
   PubMedGoogle Scholar
• . Everett BM, Glynn RJ, Danielson E, Ridker PM; Val-MARC Investigators. Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: A prespecified subgroup analysis of a community-based, randomized, open-label trial. Clin Ther. 2008; 30(4): 661–672
   PubMedGoogle Scholar
• . Punzi H, Lewin A, Lukic T, Goodin T, Chen W. Efficacy and safety of nebivolol in Hispanics with stage I–II hypertension: A randomized placebo-controlled trial. Ther Adv Cardiovasc Dis. 2010; 4(6):349–357
   PubMedGoogle Scholar
• . US Census Bureau. US population projections. Washington, DC: US Census Bureau; 2008
   Google Scholar
• . Owens AM. Hispanics in the United States. US Census Bureau, Population Division, Ethnicity and Ancestry Branch. Washington, DC: US Census Bureau; 2006
   Google Scholar
• . US Census Bureau. The Hispanic Population in the United States: 2008 Educational Attainment. Washington, DC: US Census Bureau; 2008
   Google Scholar
• . DeNavas-Walt C, Proctor BD, Smith JC. Income, Poverty, and Health Insurance Coverage in the United States: 2008. Report no. P60–236. Washington, DC: US Census Bureau, US Government Printing Office; 2009
   Google Scholar
• . Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey (NHANES). Atlanta, GA: CDC; 2009
   Google Scholar
• . Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System (BRFSS). Atlanta, GA: CDC; 2009
   Google Scholar
• . US Department of Health and Human Services, Agency for Healthcare Research and Quality. Medical expenditure panel survey. Washington, DC: US Department of Health and Human Services; 2009
   Google Scholar
• . Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010; 303(3):235–241
   PubMed Web of Science ®Google Scholar
• . National Heart, Lung, and Blood Institute. Multi-Ethnic Study of Atherosclerosis (MESA). Bethesda, MD: NHLBI; 2009
   Google Scholar
• . Neurological Institute of Columbia Presbyterian Hospital. Northern Manhattan Study (NOMAS). 2009
   Google Scholar
• . National Heart, Lung, and Blood Institute. Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Bethesda, MD: NHLBI; 2009
   Google Scholar
• . Lorenzo C, Aung K, Stern MP, Haffner SM. Pulse pressure, prehyper tension, and mortality: The San Antonio heart study. Am J Hypertens. 2009; 22(11):1219–1226
   PubMedGoogle Scholar
• . Johnson KL, Carroll JF, Fulda KG, Cardarelli K, Cardarelli R. Acculturation and self-reported health among Hispanics using a socio-behavioral model: The North Texas Healthy Heart Study. BMC Public Health. 2010; 10:53
   PubMed Web of Science ®Google Scholar
• . McWilliams JM, Meara E, Zaslavsky AM, Ayanian JZ. Differences in control of cardiovascular disease and diabetes by race, ethnicity, and education: U.S. trends from 1999 to 2006 and effects of medicare coverage. Ann Intern Med. 2009; 150(8):505–515
   PubMed Web of Science ®Google Scholar
• . Hypertension-related mortality among Hispanic subpopulations—United States, 1995–2002. MMWR Morb Mortal Wkly Rep. 2006; 55(7): 177–180
   PubMedGoogle Scholar
• . Whelton PK, He J, Appel LJ, . Primary prevention of hypertension: Clinical and public health advisory from The National High Blood Pressure Education Program. JAMA. 2002; 288(15):1882–1888
   PubMed Web of Science ®Google Scholar
• . Piña IL, Smith EV, Kessler KM, Myerburg RJ. Clinical parameters of adolescent Hispanic male hypertensive subjects: A new subject? J Clin Hypertens. 1987; 3(3):262–270
   PubMedGoogle Scholar
• . Lloyd-Jones D, Adams RJ, Brown TM, . Heart disease and stroke statistics—2010 update: A report from the American Heart Association. Circulation. 2010; 121(7):e46–e215
   PubMed Web of Science ®Google Scholar
• . Tierney EF, Geiss LS, Engelgau MM, . Population-based estimates of mortality associated with diabetes: Use of a death certificate check box in North Dakota. Am J Public Health. 2001; 91(1):84–92
   PubMedGoogle Scholar
• . Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA. 2003; 290(14):1884–1890
   PubMed Web of Science ®Google Scholar
• . US Department of Agriculture, Agricultural Research Service. Nutrient Intakes from Food: Mean Amounts Consumed per Individual, by Race/Ethnicity and Age, One Day, 2005–2006. Washington, DC: USDA; 2008
   Google Scholar
• . Colon-Ramos U, Thompson FE, Yaroch AL, . Differences in fruit and vegetable intake among Hispanic subgroups in California: Results from the 2005 California Health Interview Survey. J Am Diet Assoc. 2009; 109(11):1878–1885
   PubMedGoogle Scholar
• . Ham SA, Yore MM, Kruger J, Heath GW, Moeti R. Physical activity patterns among Latinos in the United States: Putting the pieces together. Prev Chronic Dis. 2007; 4(4):A92
   Google Scholar
• . Kruger J, Ham SA, Kohl HW 3rd. Trends in leisure-time physical inactivity by age, sex, and race/ethnicity—United States, 1994–2004. MMWR Morb Mortal Wkly Rep. 2005; 54(39):991–994
   PubMedGoogle Scholar
• . Bassett DR Jr, Fitzhugh EC, Crespo CJ, King GA, McLaughlin JE. Physical activity and ethnic differences in hypertension prevalence in the United States. Prev Med. 2002; 34(2):179–186
   PubMedGoogle Scholar
• . Cossrow N, Falkner B. Race/ethnic issues in obesity and obesity-related comorbidities. J Clin Endocrinol Metab. 2004; 89(6):2590–2594
   PubMed Web of Science ®Google Scholar
• . Brown DW, Giles WH, Greenlund KJ, Lamar-Welch V, Croft JB. Associations of hyperinsulinemia and hypertension independent of body mass among white, black, and Mexican-American adults without diabetes. Ethn Dis. 2002; 12(2):213–220
   PubMedGoogle Scholar
• . Haffner SM, Rosenthal M, Hazuda HP, Stern MP, Franco LJ. Evaluation of three potential screening tests for diabetes mellitus in a biethnic population. Diabetes Care. 1984; 7(4):347–353
   PubMedGoogle Scholar
• . Cai G, Cole SA, Haack K, Butte NF, Comuzzie AG. Bivariate linkage confirms genetic contribution to fetal origins of childhood growth and cardiovascular disease risk in Hispanic children. Hum Genet. 2007; 121(6):737–744
   PubMedGoogle Scholar
• . Cai G, Cole SA, Butte NF, Voruganti VS, Comuzzie AG. A quantitative trait locus on chromosome 13q affects fasting glucose levels in Hispanic children. J Clin Endocrinol Metab. 2007; 92(12):4893–4896
   PubMedGoogle Scholar
• . Thameem F, Voruganti VS, He X, . Genetic variants in the renin-angiotensin system genes are associated with cardiovascular-renal-related risk factors in Mexican Americans. Hum Genet. 2008; 124(5):557–559
   PubMedGoogle Scholar
• . Kammerer CM, Gouin N, Samollow PB, . Two quantitative trait loci affect ACE activities in Mexican-Americans. Hypertension. 2004; 43(2):466–470
   PubMedGoogle Scholar
• . Cai G, Cole SA, Freeland-Graves JH, MacCluer JW, Blangero J, Comuzzie AG. Principal component for metabolic syndrome risk maps to chromosome 4p in Mexican Americans: The San Antonio Family Heart Study. Hum Biol. 2004; 76(5):651–665
   PubMedGoogle Scholar
• . Voruganti VS, Nath SD, Cole SA, . Genetics of variation in serum uric acid and cardiovascular risk factors in Mexican Americans. J Clin Endocrinol Metab. 2009; 94(2):632–638
   PubMedGoogle Scholar
• . Scinicariello F, Yesupriya A, Chang MH, Fowler BA. Modification by ALAD of the association between blood lead and blood pressure in the U.S. population: Results from the Third National Health and Nutrition Examination Survey. Environ Health Perspect. 2010; 118(2):259–264
   PubMed Web of Science ®Google Scholar
• . He J, Muntner P, Chen J, Roccella EJ, Streiffer RH, Whelton PK. Factors associated with hypertension control in the general population of the United States. Arch Intern Med. 2002; 162(9):1051–1058
   PubMedGoogle Scholar
• . Spatz ES, Ross JS, Desai MM, Canavan ME, Krumholz HM. Beyond insurance coverage: Usual source of care in the treatment of hypertension and hypercholesterolemia. Data from the 2003–2006 National Health and Nutrition Examination Survey. Am Heart J. 2010; 160(1):115–121
   PubMed Web of Science ®Google Scholar
• . Stewart SH, Silverstein MD. Racial and ethnic disparity in blood pressure and cholesterol measurement. J Gen Intern Med. 2002; 17(6): 405–411
   PubMedGoogle Scholar
• . Pearson WS, Ahluwalia IB, Ford ES, Mokdad AH. Language preference as a predictor of access to and use of healthcare services among Hispanics in the United States. Ethn Dis. 2008; 18(1):93–97
   PubMed Web of Science ®Google Scholar
• . Cohen JJ. Disparities in health care: An overview. Acad Emerg Med. 2003; 10(11):1155–1160
   PubMed Web of Science ®Google Scholar
• . Cohen LL. Racial/ethnic disparities in hospice care: A systematic review. J Palliat Med. 2008; 11(5):763–768
   PubMed Web of Science ®Google Scholar
• . Cook BL, Manning WG. Measuring racial/ethnic disparities across the distribution of health care expenditures. Health Serv Res. 2009; 44 (5 pt 1):1603–1621
   PubMedGoogle Scholar
• . Fiscella K, Franks P, Gold MR, Clancy CM. Inequality in quality: Addressing socioeconomic, racial, and ethnic disparities in health care. JAMA. 2000; 283(19):2579–2584
   PubMed Web of Science ®Google Scholar
• . Hlaing WM. Race/ethnic disparity in hypertension-related hospitalization in Florida. Ethn Dis. 2007; 17(3):453–460
   PubMedGoogle Scholar
• . Shi L. Experience of primary care by racial and ethnic groups in the United States. Med Care. 1999; 37(10):1068–1077
   PubMed Web of Science ®Google Scholar
• . Shi L, Stevens GD. Disparities in access to care and satisfaction among U.S. children: The roles of race/ethnicity and poverty status. Public Health Rep. 2005; 120(4):431–441
   PubMedGoogle Scholar
• . Lillie-Blanton M, Hoffman C. The role of health insurance coverage in reducing racial/ethnic disparities in health care. Health Aff (Millwood). 2005; 24(2):398–408
   PubMed Web of Science ®Google Scholar
• . Kirby JB, Taliaferro G, Zuvekas SH. Explaining racial and ethnic disparities in health care. Med Care. 2006; 44( 5 suppl):I64–I72
   PubMed Web of Science ®Google Scholar
• . Doescher MP, Saver BG, Franks P, Fiscella K. Racial and ethnic disparities in perceptions of physician style and trust. Arch Fam Med. 2000; 9(10):1156–1163
   PubMedGoogle Scholar
• . David RA, Rhee M. The impact of language as a barrier to effective health care in an underserved urban Hispanic community. Mt Sinai J Med. 1998; 65(5–6):393–397
   PubMedGoogle Scholar
• . Solis JM, Marks G, Garcia M, Shelton D. Acculturation, access to care, and use of preventive services by Hispanics: Findings from HHANES 1982–84. Am J Public Health. 1990; 80( suppl):11–19
   PubMed Web of Science ®Google Scholar
• . Timmins CL. The impact of language barriers on the health care of Latinos in the United States: A review of the literature and guidelines for practice. J Midwifery Womens Health. 2002; 47(2):80–96
   PubMed Web of Science ®Google Scholar
• . Barquera S, Durazo-Arvizu RA, Luke A, Cao G, Cooper RS. Hypertension in Mexico and among Mexican Americans: Prevalence and treatment patterns. J Hum Hypertens. 2008; 22(9):617–626
   PubMed Web of Science ®Google Scholar
• . Castro FG. Is acculturation really detrimental to health? Am J Public Health. 2007; 97:1162
   Web of Science ®Google Scholar
• . Markides KS, Lee DJ, Ray LA. Acculturation and hypertension in Mexican Americans. Ethn Dis. 1993; 3(1):70–74
   PubMedGoogle Scholar
• . Park IU, Taylor AL. Race and ethnicity in trials of antihypertensive therapy to prevent cardiovascular outcomes: A systematic review. Ann Fam Med. 2007; 5(5):444–452
   PubMedGoogle Scholar
• . ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002; 288(23):2981–2997
   PubMed Web of Science ®Google Scholar
• . Pepine CJ, Handberg EM, Cooper-DeHoff RM, ; INVEST Investigators. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trial. JAMA. 2003; 290(21):2805–2816
   PubMed Web of Science ®Google Scholar
• . Ofili EO, Ferdinand KC, Saunders E, . Irbesartan/HCTZ fixed combinations in patients of different racial/ethnic groups with uncontrolled systolic blood pressure on monotherapy. J Natl Med Assoc. 2006; 98(4):618–626
   PubMed Web of Science ®Google Scholar
• . Ofili EO, Cable G, Neutel JM, Saunders E. Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in hypertensive women: The inclusive trial. J Womens Health (Larchmt). 2008; 17(6): 931–938
   PubMedGoogle Scholar
• . Abuissa H, Jones PG, Marso SP, O'Keefe JH Jr. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: A meta-analysis of randomized clinical trials. J Am Coll Cardiol. 2005; 46(5):821–826
   PubMed Web of Science ®Google Scholar
• . O'Keefe JH, Wetzel M, Moe RR, Bronsnahan K, Lavie CJ. Should an angiotensin-converting enzyme inhibitor be standard therapy for patients with atherosclerotic disease? J Am Coll Cardiol. 2001; 37(1):1–8
   PubMedGoogle Scholar
• . Lavie CJ, Messerli FH, Milani RV. Beta-blockers as first-line anti-hypertensive therapy the crumbling continues. J Am Coll Cardiol. 2009; 54(13):1162–1164
   PubMed Web of Science ®Google Scholar
• . Messerli FH, Bangalore S, Julius S. Risk/benefit assessment of beta-blockers and diuretics precludes their use for first-line therapy in hypertension. Circulation. 2008; 117(20):2706–2715; discussion 2715
   PubMedGoogle Scholar
• . O'Keefe JH, Abuannadi M, Lavie CJ, Bell DS. Strategies for optimizing glycemic control and cardiovascular prognosis in type 2 diabetes mellitus. Mayo Clin Proc. 2011; 86(2):128–138
   PubMed Web of Science ®Google Scholar
• . Reungjui S, Pratipanawatr T, Johnson RJ, Nakagawa T. Do thiazides worsen metabolic syndrome and renal disease? The pivotal roles for hyperuricemia and hypokalemia. Curr Opin Nephrol Hypertens. 2008; 17(5):470–476
   PubMedGoogle Scholar
• . Münzel T, Gori T. Nebivolol: The somewhat-different beta-adrenergic receptor blocker. J Am Coll Cardiol. 2009; 54(16):1491–1499
   PubMed Web of Science ®Google Scholar
• . Fonseca VA. Effects of beta-blockers on glucose and lipid metabolism. Curr Med Res Opin. 2010; 26(3):615–629
   PubMed Web of Science ®Google Scholar
• . Bakris GL, Fonseca V, Katholi RE, ; GEMINI Investigators. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: A randomized controlled trial. JAMA. 2004; 292(18):2227–2236
   PubMed Web of Science ®Google Scholar
• . Natarajan S, Santa Ana EJ, Liao Y, Lipsitz SR, McGee DL. Effect of treatment and adherence on ethnic differences in blood pressure control among adults with hypertension. Ann Epidemiol. 2009; 19(3): 172–179
   PubMed Web of Science ®Google Scholar
• . Lai LL. Community pharmacy-based hypertension disease-management program in a Latino/Hispanic-American Population. Consult Pharm. 2007; 22(5):411–416
   PubMedGoogle Scholar
• . US Census Bureau. Hispanic or Latino Origin by Specific Origin. C03001. Washington, DC: US Census Bureau; 2008
   Google Scholar